Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Acta Paediatr ; 2018 Mar 30.
Article in English | MEDLINE | ID: mdl-29603354

ABSTRACT

AIM: This study investigated the diagnostic usefulness of combined multichannel intraluminal impedance-pH monitoring (MII-pH) in children with suspected reflux-related otitis media with effusion (OME) as existing data were scarce. METHODS: This was a prospective study that included children up to seven years of age who underwent MII-pH due to OME lasting more than three months. The study was conducted in the Children's Hospital Zagreb, Croatia, from January 2014 to August 2016. RESULTS: The study comprised 63 children (63% male) with a mean age of 4.7 years. Gastroesophageal reflux (GER) disease was detected by impedance in 22 (35%) of the children and by pH-metry in nine (14%). In children with OME, MII-pH found a median number of 24 proximal GER episodes, of which a median of nine was acidic and a median of 11 was weakly acidic. There was a significant positive correlation between the number of GER episodes and the presence of eosinophils in nasal swabs. CONCLUSION: Both acidic and weakly acidic refluxes seemed to play a significant role in the pathogenesis of OME. Localised nasal eosinophilia may serve as a marker of extraoesophageal reflux in children with suspected reflux-related OME.

2.
Eur Arch Otorhinolaryngol ; 274(3): 1351-1356, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27873023

ABSTRACT

Otitis media with effusion (OME) is a common disease in childhood. There is no consensus on the optimal therapeutic option for OME. Considering the known efficacy of acetylcysteine (AC) and azithromycin (AZ) in the treatment of middle ear mucosa, the aim of the study was to assess their efficacy in the management of chronic OME. The study included 90 children with OME, both ears. They are divided into three groups of 30 children. Group 1 (AC) patients were treated with acetylcysteine per os, 3 × 100 mg, for 3 weeks; group 2 (AZ) with body weight adjusted dose of azithromycin for 3 days; and group 3 (AC + AZ) with a combination of acetylcysteine and azithromycin at doses described above. Three measurements were performed. On second measurement, tympanogram improvement was recorded in 45% of 60 ears in group I, 53.3% of 60 ears in group II, and 61.7% of 60 ears in group III. The percentage of improvement was highest in group III. Although between-group differences did not reach statistical significance, the results obtained appear to be clinically relevant. In conclusion, conservative therapy for chronic OME is reasonable. Although study results don't have a strong statistical differences and may not refer clinical improvement results suggest that this combination of drugs (antibiotics, bronchosecretolytics) can be useful in the treatment of OME.


Subject(s)
Acetylcysteine/therapeutic use , Azithromycin/therapeutic use , Otitis Media with Effusion/drug therapy , Acoustic Impedance Tests , Anti-Bacterial Agents/therapeutic use , Child , Child, Preschool , Drug Therapy, Combination , Expectorants/therapeutic use , Female , Humans , Male , Prospective Studies
3.
Acta Med Croatica ; 66 Suppl 1: 119-22, 2012 Oct.
Article in Croatian | MEDLINE | ID: mdl-23193833

ABSTRACT

Epidermolysis bullosa is a group of inherited disorders characterized by blister formation on the skin and mucous membrane as the result of molecular defects in genes coding for different structural proteins. They present with a wide clinical spectrum of manifestations because of a variety of molecular defects. Therapy depends on the form of the disease, severity and extent of skin involvement and extracutaneous manifestations, and consists of supportive skin care and supportive care for other organ systems. Skin care includes protection against trauma, proper skin care, treatment of blisters and erosions, and regular dermatological controls for early detection of skin cancer.


Subject(s)
Epidermolysis Bullosa/diagnosis , Epidermolysis Bullosa/therapy , Child , Humans , Skin Care
4.
Acta Dermatovenerol Croat ; 19(4): 255-63, 2011.
Article in English | MEDLINE | ID: mdl-22185926

ABSTRACT

Epidermolysis bullosa is a group of inherited diseases that are characterized by skin and mucosal fragility and blister formation. A wide variety of extracutaneous manifestations can develop as well as various complications of the disease such as severe anemia, growth retardation, esophageal stenosis, mutilating deformities of hands and feet, glomerulonephritis leading to chronic renal failure, and many others. One of the most important and often occurring complications is the development of cutaneous squamous cell carcinomas that grow and metastasize quickly. The objective of this paper is to give dermatologists a review of major complications encountered in patients with epidermolysis bullosa. Since these complications occur so often and can be considered to be part of the clinical picture, it is mandatory to develop a multidisciplinary well-educated team involved in follow-up and treatment of these patients.


Subject(s)
Epidermolysis Bullosa/complications , Anemia/etiology , Carcinoma, Squamous Cell/etiology , Child , Chronic Disease , Epidermolysis Bullosa/genetics , Epidermolysis Bullosa/physiopathology , Gastrointestinal Diseases/etiology , Hand Deformities/etiology , Humans , Neoplasms/etiology , Osteoporosis/etiology , Skin Neoplasms/etiology
5.
Croat Med J ; 52(4): 520-6, 2011 Aug 15.
Article in English | MEDLINE | ID: mdl-21853547

ABSTRACT

AIM: To assess the efficacy of the procedural consolidation concept (PCC) at reducing the number of sessions of general anesthesia necessary for treating children with epidermolysis bullosa (EB). METHODS: We examined the records of children treated at Children's Hospital of Zagreb between April 1999 and December 2007. Children treated before the introduction of PCC in January 2005 (n=39) and after (n=48) were analyzed in order to determine the effect of PCC on the occurrence of complications, days of hospitalization, and number of hospitalizations. RESULTS: During the study period, 53 patients underwent 220 sessions of general anesthesia for a total of 743 surgical interventions per session. Before the introduction of PCC (n=39 patients, 83 sessions), the median number of interventions per session was 2 (range 1-5), and after the introduction of PCC (n=48 patients, 137 sessions) it was 4 (range 3-7, P<0.001). After the introduction of PCC, the median number of complications per anesthesia session increased from 2 (range 0-10) to 3 (range 0-10) (P=0.027), but the median number of complications per surgical procedure decreased from 1 (range 0-10) to 0.6 (range 0-2.5) (P<0.001). PCC lengthened each anesthesia session from a median of 65 minutes (range 35-655) to 95 minutes (range 50-405), (P<0.001). Total length of hospitalization was similar before (median 1, range 1-4) and after (median 1, range 1-3) introduction of PCC (P=0.169). The number of hospitalization days per procedure was 3 times lower after the introduction of PCC (median 0.3, range 0.2-3) than before (median 1, range 0.75-1.7) (P<0.001). CONCLUSION: PCC should be considered an option in the surgical treatment of children with EB.


Subject(s)
Anesthesia, General/adverse effects , Epidermolysis Bullosa/surgery , Intraoperative Complications/etiology , Postoperative Complications/etiology , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Length of Stay , Male , Retrospective Studies , Time Factors , Young Adult
6.
Int J Pediatr Otorhinolaryngol ; 74(3): 302-5, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20044146

ABSTRACT

We report a rare case of a child with epidermolysis bullosa simplex (EBS) with plectin deficiency but without muscular dystrophy, with severe lesions of the oral cavity, oropharyngeal, hypopharyngeal, laryngeal, tracheal and bronchial mucosa. Case report and a review of the world literature are used. The literature review revealed only five similar patients with EBS without muscular dystrophy complicated by respiratory involvement. This paper highlights the potentially serious complications of the EB in the form of breathing, swallowing and speech difficulties and describes the specific problems encountered in the treatment of this patient. Epidermolysis bullosa (EB) is a group of severe hereditary diseases, primarily of the skin, but which can also involve the respiratory and gastrointestinal tract mucosa. Respiratory tract involvement is usually only found in certain types of EB. The oral cavity and oropharynx are involved more frequently than the hypopharynx, larynx and trachea. Involvement of laryngeal and tracheal mucosa is generally associated with an increased morbidity and mortality, numerous complications and therapeutic difficulties, and is more common in junctional EB and dystrophic EB than in EBS. We present a rare case of a child with EBS and plectin deficiency with pronounced lesions of respiratory tract mucosa from the oral cavity to the bronchi and even extending into the trachea. Deciding on tracheotomy requires thorough consideration and should not be taken lightly.


Subject(s)
Bronchi/pathology , Epidermolysis Bullosa/pathology , Laryngostenosis/complications , Mouth/pathology , Oropharynx/pathology , Plectin/deficiency , Trachea/pathology , Bronchi/metabolism , Bronchi/surgery , Child , Deglutition Disorders/epidemiology , Deglutition Disorders/metabolism , Epidermolysis Bullosa/complications , Epidermolysis Bullosa/surgery , Humans , Infant, Newborn , Laryngostenosis/surgery , Male , Mouth/metabolism , Mouth/surgery , Mucous Membrane/metabolism , Mucous Membrane/pathology , Oropharynx/metabolism , Oropharynx/surgery , Speech Disorders/epidemiology , Trachea/metabolism , Trachea/surgery , Tracheostomy
SELECTION OF CITATIONS
SEARCH DETAIL
...